Synthesis and Biological Evaluation of Prostaglandin-F Alkylphosphinic Acid Derivatives as Bone Anabolic Agents for the Treatment of Osteoporosis
- 2 October 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (24) , 4157-4169
- https://doi.org/10.1021/jm010264b
Abstract
A series of novel C1 alkylphosphinic acid analogues of the prostaglandin-F family have been evaluated at the eight human prostaglandin receptors for potential use in the treatment of osteoporosis. Using molecular modeling as a tool for structure-based drug design, we have discovered that the phosphinic acid moiety (P(O)(OH)R) behaves as an isostere for the C1 carboxylic acid in the human prostaglandin FP binding assay in vitro and possesses enhanced hFP receptor selectivity when compared to the parent carboxylic acid. When evaluated in vivo, the methyl phosphinic acid analogue (4b) produced a bone anabolic response in rats, returning bone mineral density (BMD) to intact levels in the distal femur in the ovariectomized rat (OVX) model. These results suggest that prostaglandins of this class may be useful agents in the treatment of diseases associated with bone loss.Keywords
This publication has 21 references indexed in Scilit:
- Three‐dimensional microimaging (MRμI and μCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosisThe Anatomical Record, 2001
- Emerging therapies for osteoporosisEmerging Drugs, 2000
- Substituent Effects on the Antibacterial Activity of Nitrogen−Carbon-Linked (Azolylphenyl)oxazolidinones with Expanded Activity Against the Fastidious Gram-Negative Organisms Haemophilus influenzae and Moraxella catarrhalisJournal of Medicinal Chemistry, 2000
- Regio- and Stereoselective Reactions of 17-Phenyl-18,19,20-trinorprostaglandin F2α Isopropyl EsterThe Journal of Organic Chemistry, 1996
- Derivatives of 17-Phenyl-18,19,20-trinorprostaglandin F2.alpha. Isopropyl Ester: Potential Antiglaucoma AgentsJournal of Medicinal Chemistry, 1995
- The Future of Hip Fractures in the United StatesPublished by Wolters Kluwer Health ,1990
- The effects of prostaglandin E2 in rapidly growing rats: Depressed longitudinal and radial growth and increased metaphyseal hard tissue massBone, 1985
- Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.Journal of Clinical Investigation, 1983
- N-(Methanesulfonyl)-16-phenoxyprostaglandin carboxamides: tissue-selective, uterine stimulantsJournal of Medicinal Chemistry, 1981
- Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart diseaseThe Journal of Pediatrics, 1980